Prothena Corporation operates as a biotechnology company. The company focuses on discovering and developing new antibodies to treat a wide range of diseases associated with protein metabolism and cell adhesion disorders.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.